EST. 2023 OPIOID-INDUCED CONSTIPATION AWARENESS DAY DECEMBER 5
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98252883
- Registration number
- 7664897
- Mark type
- Design + words
- Filed
- 02 Nov 2023
- Published for opposition
- 06 Aug 2024
- Registered
- 21 Jan 2025
- Attorney of record
- Jeremy Blackowicz
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of opioid-induced constipation and treatment of opioid-induced constipation
- Class 044 — Medical, beauty and agricultural services: Providing health information on opioid-induced constipation and treatment of opioid-induced constipation
Owner
- Salix Pharmaceuticals, Inc., Bridgewater, NJ, US
- Salix Pharmaceuticals, Inc., Bridgewater, NJ, US
- Salix Pharmaceuticals, Inc., Bridgewater, NJ, US
Prosecution history
- 14 May 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 07 May 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Oct 2024 — USE AMENDMENT FILED
- 12 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER